Didier Jutras‐Aswad
- Pharmacology top 0.2%
- Epidemiology top 5%
- Cellular and Molecular Neuroscience top 5%
- Public Health, Environmental and Occupational Health top 5%
- Pediatrics, Perinatology and Child Health top 2%
- Co-authors
- Julie BruneauYasmin L. HurdÉlise RoyGeng ZangNelson ArrudaBenedikt FischerBenjamin J. WhalleyJacqueline A. French
- Topics
- Cannabis and Cannabinoid Research (60 papers)Substance Abuse Treatment and Outcomes (54 papers)Opioid Use Disorder Treatment (48 papers)
In The Last Decade
Didier Jutras‐Aswad
136 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 129
- Pharmacology 1.6k
- Epidemiology 891
- Cellular and Molecular Neuroscience 632
- Public Health, Environmental and Occupational Health 461
- Pediatrics, Perinatology and Child Health 411
Countries citing papers authored by Didier Jutras‐Aswad
This map shows the geographic impact of Didier Jutras‐Aswad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Didier Jutras‐Aswad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Didier Jutras‐Aswad more than expected).
Fields of papers citing papers by Didier Jutras‐Aswad
This network shows the impact of papers produced by Didier Jutras‐Aswad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Didier Jutras‐Aswad. The network helps show where Didier Jutras‐Aswad may publish in the future.
Co-authorship network of co-authors of Didier Jutras‐Aswad
This figure shows the co-authorship network connecting the top 25 collaborators of Didier Jutras‐Aswad. A scholar is included among the top collaborators of Didier Jutras‐Aswad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Didier Jutras‐Aswad. Didier Jutras‐Aswad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 2 | |
| 5 | 2 | |
| 6 | 0 | |
| 7 | 3 | |
| 8 | 2 | |
| 9 | 2 | |
| 10 | 12 | |
| 11 | 1 | |
| 12 | 1 | |
| 13 | 12 | |
| 14 | 2 | |
| 15 | 38 | |
| 16 | 33 | |
| 17 | 6 | |
| 18 | 11 | |
| 19 | 6 | |
| 20 | 7 |
About Didier Jutras‐Aswad
Didier Jutras‐Aswad is a scholar working on Pharmacology, Toxicology and Epidemiology, having authored 156 papers that have together received 2.8k indexed citations. Recurring topics across this work include Cannabis and Cannabinoid Research (60 papers), Substance Abuse Treatment and Outcomes (54 papers) and Opioid Use Disorder Treatment (48 papers). The work is most often cited by research in Pharmacology (1.6k citations), Toxicology (200 citations) and Cellular and Molecular Neuroscience (632 citations). Didier Jutras‐Aswad has collaborated with scholars based in Canada, Australia and Brazil. Frequent co-authors include Julie Bruneau, Yasmin L. Hurd, Élise Roy, Geng Zang, Nelson Arruda, Benedikt Fischer, Benjamin J. Whalley, Jacqueline A. French, William Notcutt and Orrin Devinsky. Their work appears in journals such as PLoS ONE, American Journal of Psychiatry and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.